Type I Interferons in SLE pathogenesis
Could SLE immune pathophysiology offer reliable biomarkers to solve unmet needs?
Targeting complement in systemic lupus erythematosus (SLE): A translational ‘conundrum’ to be solved
Machine learning in autoimmune disease/systemic lupus erythematosus. Where are we now?